Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Clinical trial NCT01121848 · COMPLETED

Trial details

NCT number: NCT01121848
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2010-07-01
Primary completion: 2013-10-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.